Aemetis (NASDAQ:AMTX) Shares Break Below 200 Day Moving Average – Should You Sell?

Shares of Aemetis, Inc (NASDAQ:AMTX) crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $2.15 and traded as low as $1.72. Aemetis shares last traded at $1.79, with a volume of 577,930 shares.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AMTX. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research note on Friday, July 17th. Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a research note on Saturday, August 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $11.88.

Aemetis Price Performance

The business’s fifty day simple moving average is $1.79 and its 200 day simple moving average is $2.15. The stock has a market cap of $129.18 million, a price-to-earnings ratio of -1.97 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.16. The business had revenue of $62.70 million for the quarter, compared to analyst estimates of $67.69 million. As a group, equities analysts forecast that Aemetis, Inc will post -0.89 EPS for the current fiscal year.

Hedge Funds Weigh In On Aemetis

A number of large investors have recently bought and sold shares of AMTX. Bank of New York Mellon Corp bought a new position in shares of Aemetis during the second quarter valued at approximately $283,000. Bank of America Corp DE lifted its holdings in shares of Aemetis by 148.3% in the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after purchasing an additional 60,611 shares during the last quarter. Royal Bank of Canada boosted its position in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 8,825 shares during the period. Renaissance Technologies LLC acquired a new position in Aemetis during the 1st quarter valued at approximately $272,000. Finally, Sanctuary Advisors LLC bought a new position in Aemetis during the 1st quarter worth $33,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.

The company’s Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California’s Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.